LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 65

Search options

  1. Article ; Online: Clinical experience in the treatment of COVID-19 with monoclonal antibodies in solid organ transplant recipients.

    Múñez-Rubio, E / Calderón-Parra, J / Gutiérrez-Villanueva, A / Fernández-Cruz, A / Ramos-Martínez, A

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2023  Volume 36 Suppl 1, Page(s) 25–28

    Abstract: Solid organ transplant (SOT) recipients are at high risk for complications from coronavirus disease 2019 (COVID-19). SOT recipients mount lower immunological responses to vaccines than general population and are at high risk for breakthrough COVID-19 ... ...

    Abstract Solid organ transplant (SOT) recipients are at high risk for complications from coronavirus disease 2019 (COVID-19). SOT recipients mount lower immunological responses to vaccines than general population and are at high risk for breakthrough COVID-19 infections. Passive immunotherapy in the form of anti-Spike monoclonal antibodies (MoAbs) may be an alternative for the prophylaxis and treatment of COVID-19 in these patients. SARS-CoV-2 has evolved by accumulating resistance mutations that have escaped the neutralizing action of most MoAbs. However, MoAbs directed at more conserved epitopes and that maintain effector functions could maintain efficacy in the treatment of these patients. According to published data, SOT recipients with low anti-spike antibody responses to vaccination could benefit from the use of MoAbs in pre-exposure prophylaxis, in the treatment of COVID-19 mild to moderate and severe COVID-19 with less than 15 days of symptom duration and low oxygen requirements. Combination therapy could be more effective than monotherapy for the treatment of mild-to-moderate SARS-CoV-2 infection.
    MeSH term(s) Humans ; COVID-19 ; Antibodies, Monoclonal/therapeutic use ; SARS-CoV-2 ; Organ Transplantation/adverse effects
    Chemical Substances Antibodies, Monoclonal
    Language English
    Publishing date 2023-11-24
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/s01.07.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Strategies for prevention and treatment of SARS-COV-2 infection in patients with chronic kidney disease: Literature review.

    Marques Vidas, María / Muñez Rubio, Elena / Quiroga, Borja / Montejano, Rocío / Morales, Enrique / Candel, Francisco Javier

    Nefrologia

    2024  Volume 44, Issue 2, Page(s) 150–158

    Abstract: COVID-19 has proven to be particularly aggressive in patients with chronic kidney disease (CKD). The lower immune response rate and the greater susceptibility to progress to severe forms of the disease have contributed to this phenomenon, which has ... ...

    Abstract COVID-19 has proven to be particularly aggressive in patients with chronic kidney disease (CKD). The lower immune response rate and the greater susceptibility to progress to severe forms of the disease have contributed to this phenomenon, which has persisted in the post-vaccination era of the pandemic. Paradoxically, CKD has been excluded from most clinical trials of the main therapeutic tools developed against SARS-CoV-2. However, experience in the use of these drugs has been accumulating in different stages of CKD, supporting their use with guarantees of efficacy and safety. The objective of this review is to gather all treatment indications for COVID-19 in the different phases of the disease, tailored to CKD in its various stages, including renal replacement therapy.
    MeSH term(s) Humans ; COVID-19/complications ; COVID-19/prevention & control ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/therapy ; Antiviral Agents/therapeutic use ; COVID-19 Drug Treatment ; SARS-CoV-2 ; Renal Replacement Therapy ; COVID-19 Vaccines
    Chemical Substances Antiviral Agents ; COVID-19 Vaccines
    Language English
    Publishing date 2024-04-04
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 2837917-2
    ISSN 2013-2514 ; 2013-2514
    ISSN (online) 2013-2514
    ISSN 2013-2514
    DOI 10.1016/j.nefroe.2024.03.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Fosfomycin in antimicrobial stewardship programs.

    Múñez Rubio, E / Ramos Martínez, A / Fernández Cruz, A

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2019  Volume 32 Suppl 1, Page(s) 62–66

    Abstract: Due to the increase in antimicrobial resistance, strategies such as antimicrobial stewardship programs (ASP) have been developed to improve the clinical results, decrease the adverse effects and the development of resistances and ensure cost-effective ... ...

    Abstract Due to the increase in antimicrobial resistance, strategies such as antimicrobial stewardship programs (ASP) have been developed to improve the clinical results, decrease the adverse effects and the development of resistances and ensure cost-effective therapies. Fosfomycin has a unique mechanism of action against Gram-positive and Gram-negative bacteria. Cross-resistance is uncommon; however, fosfomycin should be used in combination in severe infections to avoid selecting resistant mutations. Fosfomycin's oral formulation facilitates sequential treatment, has low toxicity and high tissue penetration, even in the central nervous system and bone. Fosfomycin is active against resistant Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin- resistant enterococci and penicillin-resistant Streptococcus pneumoniae, as well as against resistant Gram-negative bacteria such as extended-spectrum beta-lactamase-producing and carbapenemase-producing enterobacteria. Fosfomycin is therefore useful for cases of persistent bacteremia, skin and soft tissue infections, as a glycopeptide-sparing and carbapenem-sparing drug for healthcare-associated infections and for polymicrobial infections. Published studies have demonstrated the synergy between fosfomycin and beta-lactams, daptomycin and glycopeptides against MSSA and MRSA; with linezolid in biofilm-associated infections and with aminoglycosides and colistin against Gram-negative bacteria, providing a nephroprotective effect.
    MeSH term(s) Animals ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Drug Resistance, Multiple, Bacterial ; Fosfomycin/therapeutic use ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/microbiology ; Gram-Positive Bacterial Infections/drug therapy ; Gram-Positive Bacterial Infections/microbiology ; Humans
    Chemical Substances Anti-Bacterial Agents ; Fosfomycin (2N81MY12TE)
    Language English
    Publishing date 2019-05-27
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Infecciones en el paciente inmunocomprometido (II). Paciente trasplantado.

    Ramos Martínez, A / Pintos Pascual, I / Múñez Rubio, E

    Medicine

    2018  Volume 12, Issue 55, Page(s) 3245–3252

    Abstract: Recipients of the different types of transplantation are at high risk of infection. Nosocomial infections predominate in patients who have undergone haematopoietic stem cell transplantation during the early post-engraftment period (30-100 days after the ... ...

    Title translation Infections in immunocompromised patients (II). The transplanted patient.
    Abstract Recipients of the different types of transplantation are at high risk of infection. Nosocomial infections predominate in patients who have undergone haematopoietic stem cell transplantation during the early post-engraftment period (30-100 days after the infusion); the incidence of infection is higher in graft-versus-host disease. Nodular lesions can appear in the lungs due to invasive fungal infection. A diffuse pattern is usually secondary to viral infection or
    Keywords covid19
    Language Spanish
    Publishing date 2018-05-08
    Publishing country Spain
    Document type English Abstract ; Journal Article
    ISSN 0304-5412
    ISSN 0304-5412
    DOI 10.1016/j.med.2018.04.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Trends in epidemiology, surgical management, and prognosis of infective endocarditis during the XXI century in Spain: A population-based nationwide study.

    Calderón-Parra, Jorge / Gutiérrez-Villanueva, Andrea / Yagüe-Diego, Itziar / Cobo, Marta / Domínguez, Fernando / Forteza, Alberto / Ana, Fernández-Cruz / Muñez-Rubio, Elena / Moreno-Torres, Victor / Ramos-Martínez, Antonio

    Journal of infection and public health

    2024  Volume 17, Issue 5, Page(s) 881–888

    Abstract: Background: Few population-based studies have evaluated the epidemiology of infective endocarditis (IE). Changes in population demographics and guidelines on IE may have affected both the incidence and outcomes of IE. Therefore, the aim of our study is ... ...

    Abstract Background: Few population-based studies have evaluated the epidemiology of infective endocarditis (IE). Changes in population demographics and guidelines on IE may have affected both the incidence and outcomes of IE. Therefore, the aim of our study is to provide contemporary population-based epidemiological data of IE in Spain.
    Methods: Retrospective nationwide observational study using data from the Spanish National Health System Discharge Database. We included all patients hospitalized with IE from January 2000 to December 2019.
    Results: A total of 64,550 IE episodes were included. The incidence of IE rose from 5.25 cases/100,000 person-year in 2000 to 7.21 in 2019, with a 2% annual percentage change (95% CI 1.3-2.6). IE incidence was higher among those aged 85 or older (43.5 cases/100.000 person-years). Trends across the study period varied with sex and age. Patients with IE were progressively older (63.9 years in 2000-2004 to 70.0 in 2015-2019, p < 0.001) and had more frequent comorbidities and predispositions, including, previous valvular prosthesis (12.1% vs 20.9%, p < 0.001). After adjustment, a progressive reduction in mortality was noted including in 2015-2019 compared to 2010-2014 (adjusted odds ratio 0.93, 95% confident interval 0.88-0.99, p = 0.023)., which was associated with more frequent cardiac surgery in recent years (15.1% in 2010-2014 vs 19.9% in 2015-2019).
    Conclusions: In Spain, the incidence of IE has increased during the XXI century, with a more pronounced increase in elderly individuals. Adjusted-mortality decreased over the years, which could be related to a higher percentage of surgery. Our results highlight the changing epidemiology of IE.
    MeSH term(s) Aged ; Humans ; Spain/epidemiology ; Retrospective Studies ; Endocarditis, Bacterial/epidemiology ; Endocarditis, Bacterial/surgery ; Endocarditis/epidemiology ; Endocarditis/surgery ; Prognosis ; Incidence
    Language English
    Publishing date 2024-03-13
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 2467587-8
    ISSN 1876-035X ; 1876-0341
    ISSN (online) 1876-035X
    ISSN 1876-0341
    DOI 10.1016/j.jiph.2024.03.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Epidemiología y clínica de las infecciones y colonizaciones causadas por enterobacterias productoras de carbapenemasas en un hospital de tercer nivel.

    Pintos-Pascual, I / Cantero-Caballero, M / Muñez Rubio, E / Sánchez-Romero, I / Asensio-Vegas, A / Ramos-Martínez, A

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2020  Volume 33, Issue 2, Page(s) 122–129

    Abstract: Objective: To describe the epidemiology of Enterobacterales producing carbapenemases (EPC) in a tertiary hospital.: Methods: A retrospective observational study, all patients with a positive sample for EPC treated in hospitalization or in the ... ...

    Title translation Epidemiology and clinical of infections and colonizations caused by Enterobacterales producing carbapenemases in a tertiary hospital.
    Abstract Objective: To describe the epidemiology of Enterobacterales producing carbapenemases (EPC) in a tertiary hospital.
    Methods: A retrospective observational study, all patients with a positive sample for EPC treated in hospitalization or in the Emergency Department were included, between January 1, 2014 and December 31, 2016.
    Results: A total of 272 patients (316 samples) were included: 155 (57%) male. Mean age of 70.4 years (95% CI 68.2 -72.7). Mean Charlson index was 3.6 (95% CI 3.4-3.8). In 63.2% the acquisition was nosocomial, in 35.3% it was health-care associated (HA). 55.1% presented infection, the most frequent infection was urinary tract infection (UTI) (58.7%). The most frequent species were Klebsiella pneumoniae (62.7%) and Enterobacter cloacae (10.1%). The most frequent types of carbapenemase were OXA-48 (53.8%) and VIM (43%). The nosocomial acquisition was associated with the male gender, transplantation, immunosuppression, admission to the Intensive Care Unit (ICU) or surgical service, prior antibiotic treatment, Enterobacter, VIM, respiratory and intra-abdominal infections. The HA acquisition was associated with age and comorbidity, nursery home origin, bladder catheterization, greater number of outpatient procedures, previous hospital admission, K. pneumoniae and E. coli, OXA-48, coproduction of extended spectrum betalactamases, UTI and sepsis.
    Conclusions: Patients who acquire EPC in nursery homes frequently have an infection. Patients with nosocomial acqui-sition are colonized by EPC in the ICU, in relation to invasive procedures and transplantation. This population has a higher mortality due to developing respiratory infections by EPC.
    MeSH term(s) Aged ; Cross Infection/epidemiology ; Cross Infection/microbiology ; Enterobacter cloacae/enzymology ; Enterobacter cloacae/isolation & purification ; Enterobacteriaceae Infections/epidemiology ; Enterobacteriaceae Infections/microbiology ; Female ; Humans ; Klebsiella pneumoniae/enzymology ; Klebsiella pneumoniae/isolation & purification ; Male ; Middle Aged ; Retrospective Studies ; Sex Distribution ; Tertiary Care Centers ; Urinary Tract Infections/epidemiology ; Urinary Tract Infections/microbiology ; beta-Lactamases/metabolism
    Chemical Substances beta-Lactamases (EC 3.5.2.6)
    Language Spanish
    Publishing date 2020-03-09
    Publishing country Spain
    Document type Journal Article ; Observational Study
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/086.2019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effect of faecal microbiota transplantation on recurrent urinary tract infection in a patient with long-term suprapubic urinary catheter.

    Ramos-Martínez, A / Martínez-Ruiz, R / Múñez-Rubio, E / Valencia-Alijo, A / Ferre-Aracil, C / Vera-Mendoza, M I

    The Journal of hospital infection

    2020  Volume 105, Issue 2, Page(s) 332–333

    MeSH term(s) Adult ; Fecal Microbiota Transplantation ; Humans ; Recurrence ; Treatment Outcome ; Urinary Catheters/adverse effects ; Urinary Catheters/microbiology ; Urinary Tract Infections/therapy
    Language English
    Publishing date 2020-01-28
    Publishing country England
    Document type Case Reports ; Letter
    ZDB-ID 779366-2
    ISSN 1532-2939 ; 0195-6701
    ISSN (online) 1532-2939
    ISSN 0195-6701
    DOI 10.1016/j.jhin.2020.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Infecciones por virus de la gripe y virus respiratorios.

    Pintos Pascual, I / Muñez Rubio, E / Alarcón Tomás, A / Ramos Martínez, A

    Medicine

    2018  Volume 12, Issue 56, Page(s) 3291–3297

    Abstract: In general, respiratory infections are benign and self-limiting, but occasionally they can cause severe symptoms and become a major cause of mortality and morbidity, especially in the more vulnerable population groups. Flu epidemics occur annually, and ... ...

    Title translation Flu virus and respiratory virus infections.
    Abstract In general, respiratory infections are benign and self-limiting, but occasionally they can cause severe symptoms and become a major cause of mortality and morbidity, especially in the more vulnerable population groups. Flu epidemics occur annually, and there can be pandemics every few years, such as those caused by types H1N1 or H3N2. The main clinical manifestations are respiratory symptoms associated with fever, and complications such as pneumonia can arise. Nasopharyngeal swab and RT-PCR should be performed to confirm the diagnosis, which can yield results for other viruses as well. Treatment is generally symptomatic, reserving neuraminidase inhibitors for the more serious cases. The best preventive measure is annual vaccination of the population at risk. The coronavirus is also particularly relevant, due to its potential prognostic implications, and the respiratory syncytial virus and parainfluenza virus should be borne in mind in children.
    Keywords covid19
    Language Spanish
    Publishing date 2018-05-09
    Publishing country Spain
    Document type English Abstract ; Journal Article
    ISSN 0304-5412
    ISSN 0304-5412
    DOI 10.1016/j.med.2018.04.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Eosinophilia and abdominal pain after severe pneumonia due to COVID 19.

    Pintos-Pascual, Ilduara / López-Dosil, Marcos / Castillo-Núñez, Ciara / Múñez-Rubio, Elena

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2021  Volume 39, Issue 9, Page(s) 478–480

    MeSH term(s) Abdominal Pain/etiology ; COVID-19 ; Eosinophilia/diagnosis ; Humans ; Pneumonia ; SARS-CoV-2
    Language English
    Publishing date 2021-08-24
    Publishing country Spain
    Document type Case Reports
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2021.08.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Eosinofilia y dolor abdominal tras una neumonía grave por COVID 19

    Pintos Pascual, I. / López Dosil, M. / Castillo Núñez, C. / Múñez Rubio, E.

    Enfermedades Infecciosas y Microbiología Clínica ; ISSN 0213-005X

    2020  

    Keywords Microbiology (medical) ; covid19
    Language Spanish
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.eimc.2020.10.014
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top